Advanced therapies in orthopaedics.
Tobias WinklerSven GeisslerTazio MaleitzkeCarsten PerkaGeorg N DudaAlexander HildebrandtPublished in: EFORT open reviews (2024)
Advanced therapies are expected to play a crucial role in supporting repair after injury, halting the degeneration of musculoskeletal tissue to enable and promote physical activity. Despite advancements, the progress in developing advanced therapies in orthopaedics lags behind specialties like oncology, since innovative regenerative treatment strategies fall short of their expectations in musculoskeletal clinical trials. Researchers should focus on understanding the mechanism of action behind the investigated target before conducting clinical trials. Strategic research networks are needed that not only enhance scientific exchange among like-minded researchers but need to include early on commercial views, companies and venture perspectives, regulatory insights and reimbursement perspectives. Only in such collaborations essential roadblocks towards clinical trials and go-to-patients be overcome.
Keyphrases
- clinical trial
- end stage renal disease
- physical activity
- ejection fraction
- stem cells
- chronic kidney disease
- phase ii
- newly diagnosed
- mesenchymal stem cells
- open label
- peritoneal dialysis
- palliative care
- prognostic factors
- phase iii
- transcription factor
- double blind
- body mass index
- patient reported outcomes
- high resolution
- depressive symptoms
- tissue engineering